The Texas Racing Commission has authorized the Texas Medical Diagnostic Laboratory to increase the amount of ELISA tests it conducts and decrease the number of screens it evaluates from urine samples collected for post-race analysis.
The Kentucky Equine Drug Research Council met Thursday at Keeneland to discuss options to identify and enforce the prohibited use of erythropoietin (EPO).
The attached list of racing organizations and officials were invited to attend a one-day workshop for the purpose of determining if agreement could be reached as to the need for a uniform policy for racehorse medication in the United States, and if so, where agreement can be reached on elements of such a policy. The workshop consisted of two segments: a two-hour open session briefing by experts on topics pertinent to the purpose of the Summit, and an intensive seven-hour workshop for the invited representatives which was conducted by a professional facilitator from outside the racing industry.
Most Popular Stories
- Phantom Dollars Flood Track's Double Pool
- How a Sire Line Develops
- Too Early to Gauge 'Brexit' Effect on Sales
- BHA Working on Strategies After 'Brexit' Vote
- Weather Impacts Churchill June 23 Program
- Legends: Joe Hirsch, Racing Ambassador
- Eutrophia to Reduce Thoroughbred Holdings
- Mohaymen Back to Work in New York
- Fairplex, Santa Anita House Evacuated Horses
- Nyquist to Work in Afternoon at Santa Anita